Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s Glenmark Confirms Abbott Sued It Over Tarka Generic (India)

This article was originally published in PharmAsia News

Executive Summary

India's Glenmark Pharmaceuticals confirms Abbott Laboratories has sued it in the United States to block its FDA application for a generic version of Tarka (trandolapril, verapamil hydrochloride) for treating hypertension. Glenmark believes it was the first to file for a generic, the first for the company, but Abbott said the application violates its patent. Tarka has generated $100 million in U.S. sales for Abbott. (Click here for more ) "Glenmark Confirms Abbott Suit Against Tarka Generic" Economic Times (India) (12/13/07)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065870

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel